HUE040503T2 - Kezelési eljárások ammónia-leválasztó gyógyszerek használatával - Google Patents
Kezelési eljárások ammónia-leválasztó gyógyszerek használatávalInfo
- Publication number
- HUE040503T2 HUE040503T2 HUE16176456A HUE16176456A HUE040503T2 HU E040503 T2 HUE040503 T2 HU E040503T2 HU E16176456 A HUE16176456 A HU E16176456A HU E16176456 A HUE16176456 A HU E16176456A HU E040503 T2 HUE040503 T2 HU E040503T2
- Authority
- HU
- Hungary
- Prior art keywords
- ammonia
- treatment
- methods
- scavenging drugs
- scavenging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9323408P | 2008-08-29 | 2008-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE040503T2 true HUE040503T2 (hu) | 2019-03-28 |
Family
ID=45604478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE09739263A HUE029912T2 (hu) | 2008-08-29 | 2009-01-07 | Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával |
| HUE16176456A HUE040503T2 (hu) | 2008-08-29 | 2009-01-07 | Kezelési eljárások ammónia-leválasztó gyógyszerek használatával |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE09739263A HUE029912T2 (hu) | 2008-08-29 | 2009-01-07 | Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával |
Country Status (10)
| Country | Link |
|---|---|
| JP (3) | JP5577341B2 (hu) |
| DK (1) | DK3133396T3 (hu) |
| ES (2) | ES2593378T3 (hu) |
| HR (2) | HRP20161222T1 (hu) |
| HU (2) | HUE029912T2 (hu) |
| LT (2) | LT3133396T (hu) |
| PL (1) | PL2330892T3 (hu) |
| PT (2) | PT2330892T (hu) |
| SI (1) | SI3133396T1 (hu) |
| TR (1) | TR201816616T4 (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX366197B (es) | 2011-09-30 | 2019-06-25 | Horizon Therapeutics Llc | Metodo de monitoreo terapeutico de farmacos depuradores de nitrogeno. |
| BR112014026138A2 (pt) * | 2012-04-20 | 2017-06-27 | Hyperion Therapeutics Inc | métodos de monitoramento terapêutico de pró-fármacos de ácido fenilacético |
| RS56757B1 (sr) * | 2012-11-21 | 2018-04-30 | Horizon Therapeutics Llc | Postupci davanja i procene lekova za uklanjanje azota za lečenje hepatične encefalopatije |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| US20220044801A1 (en) * | 2018-10-04 | 2022-02-10 | Atonarp Inc. | Living body information acquisition system, health management server, and system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| DE69612755T2 (de) * | 1995-02-07 | 2001-08-23 | Brusilow Entpr Llc | Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
-
2009
- 2009-01-07 PL PL09739263T patent/PL2330892T3/pl unknown
- 2009-01-07 TR TR2018/16616T patent/TR201816616T4/tr unknown
- 2009-01-07 PT PT97392633T patent/PT2330892T/pt unknown
- 2009-01-07 JP JP2011525021A patent/JP5577341B2/ja active Active
- 2009-01-07 LT LTEP16176456.8T patent/LT3133396T/lt unknown
- 2009-01-07 HU HUE09739263A patent/HUE029912T2/hu unknown
- 2009-01-07 ES ES09739263.3T patent/ES2593378T3/es active Active
- 2009-01-07 PT PT16176456T patent/PT3133396T/pt unknown
- 2009-01-07 LT LTEP09739263.3T patent/LT2330892T/lt unknown
- 2009-01-07 HU HUE16176456A patent/HUE040503T2/hu unknown
- 2009-01-07 DK DK16176456.8T patent/DK3133396T3/en active
- 2009-01-07 ES ES16176456T patent/ES2695534T3/es active Active
- 2009-01-07 SI SI200931886T patent/SI3133396T1/sl unknown
- 2009-08-27 JP JP2011525214A patent/JP2012501451A/ja not_active Withdrawn
-
2014
- 2014-01-07 JP JP2014000920A patent/JP2014102255A/ja not_active Withdrawn
-
2016
- 2016-09-26 HR HRP20161222TT patent/HRP20161222T1/hr unknown
-
2018
- 2018-11-08 HR HRP20181877TT patent/HRP20181877T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3133396T1 (sl) | 2018-12-31 |
| LT3133396T (lt) | 2018-11-26 |
| PL2330892T3 (pl) | 2017-05-31 |
| HRP20181877T1 (hr) | 2019-01-11 |
| ES2593378T3 (es) | 2016-12-09 |
| HUE029912T2 (hu) | 2017-03-28 |
| JP2014102255A (ja) | 2014-06-05 |
| PT3133396T (pt) | 2018-12-07 |
| DK3133396T3 (en) | 2018-12-03 |
| LT2330892T (lt) | 2016-11-25 |
| TR201816616T4 (tr) | 2018-11-21 |
| JP5577341B2 (ja) | 2014-08-20 |
| HRP20161222T1 (hr) | 2017-02-10 |
| PT2330892T (pt) | 2016-09-05 |
| JP2012501329A (ja) | 2012-01-19 |
| JP2012501451A (ja) | 2012-01-19 |
| ES2695534T3 (es) | 2019-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1600057I1 (hu) | Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával | |
| IL208354A0 (en) | Methods of treatment | |
| HK1169804A1 (zh) | 治療疼痛的方法 | |
| ZA201106730B (en) | Methods of treatment using combination therapy | |
| EP2300011A4 (en) | METHODS AND THERAPEUTIC COMPOUNDS | |
| HRP20181877T1 (hr) | Postupci za liječenje lijekovima koji uklanjaju amonijak | |
| HUS1600039I1 (hu) | Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával | |
| EP2350641A4 (en) | Methods of Treatment | |
| EP3381471C0 (en) | PAIN TREATMENT | |
| EP2164494A4 (en) | Methods of Treatment | |
| GB0723100D0 (en) | Treatment of HFnEF | |
| HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
| GB2460445B (en) | Treatment of ringworm | |
| SI2330892T1 (sl) | Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak | |
| EP2440238A4 (en) | Methods of Treatment | |
| EP2203432A4 (en) | PROCESSING METHOD | |
| GB0700969D0 (en) | Methods of treatment | |
| GB0819543D0 (en) | Treatment of proteostatic disease | |
| GB0817859D0 (en) | Treatment of proteostatic disease | |
| GB0823435D0 (en) | Method of treatment | |
| GB0717337D0 (en) | Method of treatment | |
| GB0803515D0 (en) | Medicament and method of treatment | |
| AU2008902372A0 (en) | Methods of treatment | |
| GB0720136D0 (en) | Treatment of blood disorded | |
| GB0804468D0 (en) | Treatment of influenza |